536565 TRIMURTHI

Novelix Pharmaceuticals Share Price

 

 

Start SIP in TRIMURTHI

Start SIP

Performance

  • Low
  • ₹60
  • High
  • ₹64
  • 52 Week Low
  • ₹25
  • 52 Week High
  • ₹70
  • Open Price₹63
  • Previous Close₹63
  • Volume5,214
  • 50 DMA₹59.31
  • 100 DMA₹55.18
  • 200 DMA₹46.60

Investment Returns

  • Over 1 Month + 16.86%
  • Over 3 Month + 6.46%
  • Over 6 Month + 49.18%
  • Over 1 Year + 140.63%

Smart Investing Starts Here Start SIP with Novelix Pharmaceuticals for Steady Growth!

Invest Now

Novelix Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 58.8
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 108
  • P/B Ratio
  • 3.7
  • Average True Range
  • 3.94
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 1.19
  • RSI
  • 50.61
  • MFI
  • 66.75

Novelix Pharmaceuticals Financials

Novelix Pharmaceuticals Technicals

EMA & SMA

Current Price
₹61.00
-1.96 (-3.11%)
pointer
  • Bearish Moving Average 7
  • Bullish Moving Average 9
  • 20 Day
  • ₹61.34
  • 50 Day
  • ₹59.31
  • 100 Day
  • ₹55.18
  • 200 Day
  • ₹46.60

Resistance and Support

61.75 Pivot Speed
  • R3 67.67
  • R2 65.93
  • R1 63.49
  • S1 59.31
  • S2 57.57
  • S3 55.13

Novelix Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-12 Quarterly Results
2025-11-13 Quarterly Results
2025-08-14 Quarterly Results & A.G.M.
2025-06-24 Others Inter alia, to consider and approve 1. The conversion of Warrants into Equity Shares of the Company.
2025-05-27 Audited Results

Novelix Pharmaceuticals F&O

Novelix Pharmaceuticals Shareholding Pattern

50.8%
44%
5.2%

Novelix Pharmaceuticals FAQs

Novelix Pharmaceuticals share price is ₹61 As on 22 February, 2026 | 14:20

The Market Cap of Novelix Pharmaceuticals is ₹107.5 Cr As on 22 February, 2026 | 14:20

The P/E ratio of Novelix Pharmaceuticals is 58.8 As on 22 February, 2026 | 14:20

The PB ratio of Novelix Pharmaceuticals is 3.7 As on 22 February, 2026 | 14:20

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23